Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing-Reference-Cited by-同舟云学术

Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

Published:2010-02-24 Issue:20 Volume:2 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Leary Rebecca J.¹,Kinde Isaac¹,Diehl Frank¹,Schmidt Kerstin¹,Clouser Chris²,Duncan Cisilya²,Antipova Alena²,Lee Clarence²,McKernan Kevin²,De La Vega Francisco M.³,Kinzler Kenneth W.¹,Vogelstein Bert¹,Diaz Luis A.¹,Velculescu Victor E.¹

Affiliation:

1. Ludwig Center for Cancer Genetics and Therapeutics and Howard Hughes Medical Institute, Johns Hopkins Kimmel Cancer Center, Baltimore, MD 21231, USA.

2. Life Technologies, Beverly, MA 01915, USA.

3. Life Technologies, Foster City, CA 94404, USA.

Abstract

Rapid detection of specific aberrant rearrangements in tumors from individuals yields a well-poised technological advance toward personalized oncology.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference29 articles.

1. Genetic instabilities in human cancers

2. The impact of translocations and gene fusions on cancer causation

3. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays

4. Representational Oligonucleotide Microarray Analysis: A High-Resolution Method to Detect Genome Copy Number Variation

5. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping

Cited by 430 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Language model enables end-to-end accurate detection of cancer from cell-free DNA;Briefings in Bioinformatics;2024-01-22

2. Nanomedicine and epigenome: Possible health risks, benefits, and future perspectives;Cancer Epigenetics and Nanomedicine;2024

3. Delta-radiomics in cancer immunotherapy response prediction: A systematic review;European Journal of Radiology Open;2023-12

4. Leveraging Complexity in Oncology – A Data Narrative;Complexities 1;2023-12

5. A Practical Approach for Targeting Structural Variants Genome-wide in Plasma Cell-free DNA;2023-10-27